Does SUVOREXANT Cause Interstitial lung disease? 16 Reports in FDA Database
Wake Up Pain-Free — Sleep Like Never Before
Derila Ergo Pillow: ergonomic design, cooling tech. 75% OFF today.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Interstitial lung disease have been filed in association with SUVOREXANT (BELSOMRA). This represents 0.2% of all adverse event reports for SUVOREXANT.
16
Reports of Interstitial lung disease with SUVOREXANT
0.2%
of all SUVOREXANT reports
6
Deaths
12
Hospitalizations
How Dangerous Is Interstitial lung disease From SUVOREXANT?
Of the 16 reports, 6 (37.5%) resulted in death, 12 (75.0%) required hospitalization, and 3 (18.8%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SUVOREXANT. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does SUVOREXANT Cause?
Drug ineffective (2,855)
Nightmare (723)
Somnolence (639)
Abnormal dreams (588)
Insomnia (529)
Feeling abnormal (427)
Headache (421)
Hallucination (338)
No adverse event (327)
Fatigue (231)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which SUVOREXANT Alternatives Have Lower Interstitial lung disease Risk?
SUVOREXANT vs SUZETRIGINE
SUVOREXANT vs SYMBICORT
SUVOREXANT vs SYNAGIS
SUVOREXANT vs SYNTHROID
SUVOREXANT vs TACROLIMUS